☸️SAIMSARA Journal
Online First Issues About Impressum

AI-Native Scoping Reviews & Evidence Mapping

ISSN 3054-3991 · ISSN record ↗
The Journal publishes machine-generated scoping reviews in medical and life sciences under human-editorial oversight, with transparent citations and versioning. Online First articles are continuously released by registered users. Issues are organized by domain and linked to an interactive AI RAG chatbot.
Editor's Choice papers are marked with .

Read aims & scope, publishing model & policies →

Issues

Domain issues provide a same-page filtered article view and a paired RAG agent.
Cardiac & Vascular Health icon
Cardiac & Vascular Health
Issue 1 • Vol 1 (2026) in progress
Longevity & Public Health icon
Longevity & Public Health
Issue 2 • Vol 1 (2026) in progress
Digital Health & Biotech icon
Digital Health & Biotech
Issue 3 • Vol 1 (2026) in progress
Mental & Neurological Health icon
Mental & Neurological Health
Issue 4 • Vol 1 (2026) in progress
Sports Medicine icon
Sports Medicine
Issue 5 • Vol 1 (2026) in progress
Pain Medicine icon
Pain Medicine
Issue 6 • Vol 1 (2026) in progress
Infectious Diseases icon
Infectious Diseases
Issue 7 • Vol 1 (2026) in progress
Skin & Aesthetics icon
Skin & Aesthetics
Issue 8 • Vol 1 (2026) in progress
Gastrointestinal & Metabolic Health icon
Gastrointestinal & Metabolic Health
Issue 9 • Vol 1 (2026) in progress
To propose a new domain issue or suggest curation criteria, use Impressum contact.
Online First: 206 article(s) • Page 4 / 18 Full archive (source) →
Cardiac & Vascular Health Cardiac & Vascular Health
TEndurant is not just another EVAR device story: this review shows where its long-term durability is real, and where it becomes fragile. The full read maps registry, hostile-neck, chimney, EndoAnchor, limb, renal, and late endoleak evidence to clarify a practical point for vascular specialists: Endurant success is driven less by deployability and more by proximal sealing quality, anatomy, and surveillance.
Updated: 2026-05-30 • ID: endurant-stent-20260521-180429-125b2ae2
Cardiac & Vascular Health Cardiac & Vascular Health
Erectile dysfunction is often treated as a private urological complaint, but this review shows why it may be an early vascular warning signal. The full read maps more than 800 original studies to clarify how vasculogenic ED overlaps with cardiovascular risk, subclinical atherosclerosis, diabetes, hypertension, PDE5 inhibitor safety, and the need for integrated urology–cardiology care.
Updated: 2026-05-30 • ID: cardiovascular-erectile-dysfunction-20260521-180136-d8b0bda9
Cardiac & Vascular Health Cardiac & Vascular Health
Flow diverters have reshaped aneurysm treatment, but their success depends heavily on anatomy, device behavior, and procedural strategy. The full read maps 252 references and 1439 original studies to separate strong indications from high-risk zones, giving a practical evidence overview for clinicians, researchers, and endovascular teams.
Updated: 2026-05-30 • ID: flow-diverter-20260521-174838-0494831d
Longevity & Public Health Longevity & Public Health
This review separates the vaping–“popcorn lung” concern from hype by showing that the current evidence is biologically plausible and clinically observed, but still low-certainty. The full read is valuable because it maps the rare human cases, chemical exposure data, occupational diacetyl precedent, and major evidence gaps in one structured evidence map.
Updated: 2026-05-30 • ID: cigarette-bronchiolitis-obliterans-constrictive-bronchioliti-20260530-073819-c97ceff8 • Editorial check 2026-05-30
Cardiac & Vascular Health Cardiac & Vascular Health
Stent retrievers are no longer just a device story; this review shows them as a full procedural ecosystem where aspiration strategy, device sizing, balloon-guide support, clot biology, and first-pass optimization shape real clinical success. The full read is valuable because it separates where stent-retriever thrombectomy is firmly evidence-based from where practice is still driven by anatomy, technique, emerging devices, and lower-certainty frontier applications.
Updated: 2026-05-30 • ID: stent-retriever-20260521-174743-1e6b954c
Cardiac & Vascular Health Cardiac & Vascular Health
Viabahn is not one device story but a whole vascular strategy: emergency bleeding control, femoropopliteal reconstruction, dialysis-access salvage, aneurysm exclusion, and complex aortic bridging all appear in the evidence map. The full review separates where Viabahn and VBX look durable from where patency depends heavily on anatomy, sizing, runoff, mobility zones, and antiplatelet planning.
Updated: 2026-05-29 • ID: viabahn-stent-20260520-194133-e1c09738
Cardiac & Vascular Health Cardiac & Vascular Health
Supera is not just another femoropopliteal stent story: the evidence shows a device whose success depends heavily on deployment precision, vessel preparation, lesion mechanics, and anatomical stress. The full review separates durable patency signals from real-world failure zones, including elongation, fracture, popliteal stress, dialysis-access uncertainty, and off-label use beyond the core femoropopliteal indication.
Updated: 2026-05-29 • ID: supera-stent-20260520-194032-32125f88
Cardiac & Vascular Health Cardiac & Vascular Health
PCSK9 base editing is moving from experimental promise toward clinical reality, with single-dose therapies already producing durable LDL-C reductions in both primates and early human studies. The full evidence map reveals which delivery platforms, editing strategies, and safety signals are driving this transition—and where the remaining uncertainties still lie.
Updated: 2026-05-29 • ID: pcsk9-base-editing-20260520-180050-bcdd5697
Longevity & Public Health Longevity & Public Health
Surgery does not end when the operation ends: this review shows that across oncology, bariatrics, orthopedics, transplantation, and vascular care, postoperative medication adherence is often the hidden determinant of recurrence, complications, and survival. The full read is worth it because it separates where adherence reliably fails, which barriers drive that failure, and which interventions actually help keep patients on treatment after discharge.
Updated: 2026-05-29 • ID: medication-adherence-after-surgery-20251126-192700-c08385f4
Longevity & Public Health Longevity & Public Health
Nicotine pouches sit at the centre of a public-health paradox: they may reduce toxicant exposure for adult smokers who fully switch, yet the evidence map shows rapid youth uptake driven by flavors, TikTok visibility, product appeal, and aggressive marketing. The full review separates harm-reduction promise from initiation risk, mapping 109 references across pharmacokinetics, oral safety, biomarkers, youth use, regulation, and the fast-moving nicotine-analogue market.
Updated: 2026-05-28 • ID: nicotine-pouch-20260528-124059-df0814e3 • Editorial check 2026-05-28
Cardiac & Vascular Health Cardiac & Vascular Health
Giant cell myocarditis is rare, but the evidence map shows why it should never be treated as a diagnostic afterthought: survival depends on early biopsy, rapid combination immunosuppression, and timely escalation to mechanical support or transplantation. The full review distills 169 references into a practical map of prognosis, arrhythmia risk, cardiac sarcoidosis overlap, relapse surveillance, and the unresolved gaps that still shape real-world management.
Updated: 2026-05-28 • ID: giant-cell-myocarditis-20260520-175304-4bbcdf64
Longevity & Public Health Longevity & Public Health
Falsified medical products are not a niche drug-safety problem, but a supply-chain failure spanning medicines, devices, online pharmacies, informal markets, and weak regulatory systems. The full evidence map shows where risk concentrates — from semaglutide and PDE-5 products to vaccines, antibiotics, devices, and digital marketplaces — and which detection, reporting, and regulatory tools can realistically close the gaps.
Updated: 2026-05-27 • ID: falsified-medical-product-20260519-174803-b2913b49
© 2026 SAIMSARA Journal • Impressum • Published by ML in Health Science GbR